CELL ID

About CELL ID

CELL ID PTE. LTD. is a Singapore-based medical technology company established in 2014, specializing in the development and manufacturing of point-of-care (POC) molecular diagnostic solutions. The company was co-founded by Neo Siak Peng and Xander Sim, who serves as the Chief Technology Officer. CELL ID's core mission is to provide rapid and accurate diagnostic tools for infectious diseases, particularly in resource-limited settings where traditional laboratory testing is not readily accessible.

The company's business model centers on the principle of adapting mature technologies for novel diagnostic applications, a strategy designed to accelerate time-to-market and minimize development costs. This approach of 'not reinventing the wheel' allows them to strategically fill critical niches within the biomedical sector by collaborating with clinicians, researchers, and industry partners. Revenue is generated through the manufacturing and sale of its diagnostic instruments and the associated consumable supplies, such as reagents.

CELL ID's flagship product line is built upon its proprietary Disposable PCR technologies. This includes the Quiz bio-chip, which is used in conjunction with the POCHE dongle and a corresponding mobile application. This integrated system performs real-time RT-LAMP assays for the qualitative detection of various infectious diseases, including Malaria, HIV-1/2, and COVID-19. The portability of these devices eliminates the need to send samples to a centralized laboratory, significantly reducing turnaround times and enabling healthcare providers to make swift, near-patient diagnoses. The company has also developed a molecular probe for the early diagnosis of breast cancer and holds intellectual property for a single-use HIV detection device and a pregnancy test kit.